BUY Sai Life Sciences — Prabhudas Lilladher
byPrabhudas LilladherHorizon: NA (inferred 1 year)21 Oct 2026via Moneycontrol Broker Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Buy Sai Life Sciences; target of Rs 1620: Prabhudas Lilladher
NewsGoogle News·21 Oct · today
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·21 Oct · yesterday
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·6 Oct · 2w ago
This multibagger pharma stock is down 10% from record high—CFO reveals growth plan
NewsCnbc-Tv18·30 Sept · 3w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Sai Life Sciences
- BUY — Swati Hotkar, Nirmal Bang Securities6 Oct 2026 · ~3 months · target ₹1,650 · Active
- BUY — Rupak De, LKP Securities25 Sept 2026 · ~2 weeks · target ₹1,750 · SL hit
- BUY — Kunal Bothra16 Sept 2026 · ~2 weeks · target ₹1,700 · Expired
- BUY — Shrikant Chouhan, Kotak Securities16 Sept 2026 · ~2 weeks · target ₹1,900 · Expired
- BUY — Himanshu Gupta8 Sept 2026 · ~3 months · target ₹1,800 · SL hit
More from Prabhudas Lilladher
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹200 · Active
- BUY Nestle India15 Oct 2026 · ~1 year · target ₹1,526 · Active
- BUY Tata Elxsi14 Oct 2026 · ~1 year · target ₹3,790 · Target hit
- SELL Avenue Supermarts12 Oct 2026 · ~3 months · target ₹3,214 · Target hit
- BUY Can Fin Homes12 Oct 2026 · ~1 year · target ₹1,090 · Active

